Cafepharma Today

September 6 2024 - FDA concerned Iterum’s urinary tract infection drug could cause antimicrobial resistance
FDA concerned Iterum’s urinary tract infection drug could cause antimicrobial resistance
Edwards cuts more than 500 employees after critical care sale
Bristol-Myers Squibb-backed Zenas BioPharma seeks up to $689.7 mln valuation in US IPO
What 3 layoff stories reveal about pharma’s troubles
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

ImClone's Erbitux to Get Quicker Review by U.S. FDA
Bloomberg
Friday, October 31, 2008 - 8:48am
tags:
AstraZeneca Chooses Acquisitions Over Buybacks, Joining Glaxo
Bloomberg
Thursday, October 30, 2008 - 12:08pm
tags:
Mylan Profit Jumps 15% on Sale of Blood-Pressure Drug
Bloomberg
Thursday, October 30, 2008 - 12:06pm
tags:
Novo May Spend as Much as $2 Billion on Takeovers
Bloomberg
Thursday, October 30, 2008 - 12:06pm
tags:
Drug stocks rally in wake of Fed rate cut
Marketwatch
Thursday, October 30, 2008 - 12:05pm
tags:
A Strong Season for AstraZeneca’s Cholesterol Drug Crestor
WSJ Online
Thursday, October 30, 2008 - 12:03pm
tags:
Do Newly-Released FDA Memos Hurt Wyeth’s Preemption Argument?
WSJ Online
Thursday, October 30, 2008 - 11:27am
tags:
Glaxo's Avandia Should Be Banned, Public Citizen Says
Bloomberg
Thursday, October 30, 2008 - 11:14am
tags:
Elan, Biogen Plunge After Brain Illness Strikes Tysabri Patient
Bloomberg
Thursday, October 30, 2008 - 11:10am
tags:
Johnson & Johnson: Still Adding to My Position
Seeking Alpha
Thursday, October 30, 2008 - 11:09am
tags:
AstraZeneca Beats Forecasts, Raises Year Guidance
CNBC
Thursday, October 30, 2008 - 11:08am
tags:
More R&D: Not Boosting Big Pharma
Businessweek
Thursday, October 30, 2008 - 11:08am
tags:
How Many People Take Cholesterol Drugs?
Forbes
Thursday, October 30, 2008 - 11:06am
tags:
Wyeth Cuts Back Too: Are New Opportunities Being Created?
Seeking Alpha
Thursday, October 30, 2008 - 11:05am
tags:
GlaxoSmithKline to acquire Genelabs Technologies for $57 million, boost hepatitis C efforts
Yahoo/AP
Thursday, October 30, 2008 - 11:04am
tags:
FDA Official: Preemption Argument ‘Based On a False Assumption’
WSJ Online
Thursday, October 30, 2008 - 10:49am
tags:
Wyeth narrowing focus of research to 6 areas, shifting women's health research to new diseases
Yahoo/AP
Thursday, October 30, 2008 - 10:49am
tags:
Biotech funding crisis poses risks to innovation
Guardian, UK
Wednesday, October 29, 2008 - 5:24pm
tags:
Biogen Says Brain Illness Found in Tysabri Patient
Bloomberg
Wednesday, October 29, 2008 - 5:22pm
tags:
Allergan reduces expectations in 2008, and says economic woes will cut 2009 profit growth
Yahoo/AP
Wednesday, October 29, 2008 - 5:22pm
tags:

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

Humira Biosimilar Price War Update: Should We Be Glad that CVS Health and Express Scripts Are Using Private Label Products to Pop the Gross-to-Net Bubble?
Drug Channels
The Healthcare Innovation Company's Value-Based Care Summit
Drug Channels
Embedding Into the Provider’s Workflow is Key to a Specialty Drug’s Success
Drug Channels
Drug Channels News Roundup, August 2024: My $0.02 on the IRA’s MFPs, UNC’s New PBM, Amazon vs. Retail, Fixing 340B, and Mark Cuban Lets Loose
Drug Channels
When Payers Become Producers: Inside the PBM Private-Labeling Trend
Drug Channels
Can Rite Aid Recover?
Drug Channels
IRA Reality Check: Four Strategies for Adapting Hub and Copay Programs
Drug Channels
Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (Video)
Drug Channels
Mid-Year Hub Review: Five Considerations for Staying Ahead of the Curve
Drug Channels

Latest Jobs

Pharmaceutical Sales Customer Engagement, CNS - Los Angeles W, CA
Los Angeles, California,
Otsuka
Pharmaceutical Sales Customer Engagement - Chicago, IL
Chicago, Illinois,
Otsuka
Sales Representative - Paid Training
Caldwell, Idaho, 83607
Bartlett Roofing
Pharmaceutical Sales Customer Engagement- Poughkeepsie, NY
Poughkeepsie, New York,
Otsuka
Medical Device Sales Specialist
Durham, North Carolina
B. Braun Medical Inc
Pharmaceutical Sales Customer Engagement - Parkersburg, WV
West Virginia, West Virginia,
Otsuka
Pharmaceutical Sales Customer Engagement- Baltimore South
Baltimore, Maryland,
Otsuka
Pharmaceutical Sales Customer Engagement - Hinsdale, IL
Illinois, Illinois,
Otsuka
Regional Sales Manager - Central Texas
Dripping Springs, Texas, 78620
Clinical Pathology Laboratories, Inc
Regional Sales Manager - Central Texas
Georgetown, Texas, 78628
Clinical Pathology Laboratories, Inc
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information